Short stature due to a defect in growth hormone receptor or post receptor pathway (Q97202): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Síndrome de insensibilidade ao hormônio do crescimento (SIGH) é um grupo de doenças caracterizado por baixa estatura importante associada a concentrações normais ou elevadas de hormônio do crescimento (GH), que não responde à administração exógena de GH. SIGH compreende atraso de crescimento devido a deficiência de IGF-1, atraso de crescimento devido a resistência ao IGF-1, síndrome de Laron, baixa estatura devido a deficiência de STAT5b e deficiência primária de subunidade ácido-lábil (ALS). (veja estes termos) | |||||||||||||||
| description / en | description / en | ||||||||||||||
Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms). | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/510125881 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_510125881 | |||||||||||||||
| Property / CURIE: CID11:ID_510125881 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_510125881 | |||||||||||||||
| Property / Canary Token: dki-india-ID_510125881 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:15, 16 August 2026
Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_510125881 |
||
| English | Short stature due to a defect in growth hormone receptor or post receptor pathway |
Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms). |
Statements
CID11:ID_510125881
0 references
dki-india-ID_510125881
0 references
Concluído
0 references
15 August 2026
0 references
